Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/8/2017
SIETES contiene 91969 citas

 
 
 1 a 20 de 4892 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]
2. Cita con resumen
Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, Li N, Lu Y, Su T, Sun J, Wang J, Yue Z, Zhang W, Zhao J, Zhou Z, Wu J, Zhou K, Ai Y, Zhou J, Pang R, Wang Y, Qin Z, Yan S, Li H, Luo L, Liu B. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA 2017;317:2493-501. [Ref.ID 101928]
3. Cita con resumen
Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernández-Díaz S. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017;376:2245-54. [Ref.ID 101629]
4. Cita con resumen
Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications. Pharmacoepidemiol Drug Saf 2017;26:712-21. [Ref.ID 101627]
5.Enlace a cita original Cita con resumen
Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ 2017;357:j2350. [Ref.ID 101616]
6. Cita con resumen
Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM. Association of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA 2017;317:1553-62. [Ref.ID 101557]
7.Enlace a cita original Cita con resumen
Shen Z-Q, Gao S-Y, Li SX, Zhang T-N, Liu C-X, Lv H-C, Zhang Y, Gong T-T, Xu X, Ji C, Wu Q-J, Li D. Sertraline use in the first trimester and risk of congenital anomalies: a systematic review and meta-analysis of cohort studies. Br J Clin Pharmacol 2017;83:909-22. [Ref.ID 101518]
8.Enlace a cita original Cita con resumen
Graner S, Svensson T, Beau A-B, Damase-Michel C, Engeland A, Furu K, Hviid A, Haberg SE, Molgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017;356:j629. [Ref.ID 101465]
9. Cita con resumen
Anónimo. Femmes enceintes atteintes d'une maladie de Basedow. Prescrire 2017;37:193-8. [Ref.ID 101458]
10. Cita con resumen
Anónimo. Pertuzumab et cancers du sein métastasés. Prescrire 2017;37:94-5. [Ref.ID 101441]
11. Cita con resumen
Anónimo. Pertuzumab avant la chirurgie d'un cancer du sein. Prescrire 2017;37:92-4. [Ref.ID 101440]
12.Enlace a cita original Cita con resumen
Wang R, Kim BV, van Wely M, Johnson NP, Costello MF, Zhang H, Ng EHY, Legro RS, Bhattacharya S, Norman RJ, Mol BWJ. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ 2017;356:j138. [Ref.ID 101407]
13. Cita con resumen
Alijotas-Reig J, Esteve-Valverde E. Embarazo y enfermedades autoinmunitarias. Med Clin (Barc) 2017;148:161-3. [Ref.ID 101400]
14. Cita con resumen
Velzel J, Vlemmix F, Opmeer BC, Molkenboer JFM, Verhoeven CJ, van Pampus MG, Papatsonis DNM, Bais JMJ, Vollebregt KC, van der Esch L, van der Post JAM, Mol BW, Kok M. Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial. BMJ 2017;356:i6773. [Ref.ID 101398]
15. Cita con resumen
Anónimo. Troxérutine et grossesse: malformations?. Prescrire 2017;37:25. [Ref.ID 101366]
16. Cita con resumen
Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M, Strong M, Selby P, Gittoes N. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technol Assess 2016;20:1-406. [Ref.ID 101044]
17.Enlace a cita original Cita con resumen
Anónimo. Anticonceptivos hormonales: selección adecuada. Boletín Terapéutico Andaluz 2016;31:1-10. [Ref.ID 101040]
18. Cita con resumen
Finn RS, Martin M, Rugo HS, Jones S, Im S-A, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Diéras V, Slamon DJ. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 2016;375:17 de noviembre. [Ref.ID 100990]
20. Cita con resumen
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Balckwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobssen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J. Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med 2016;375:1738-48. [Ref.ID 100961]
Seleccionar todas
 
 1 a 20 de 4892 siguiente >>